Viewpoints
Advertisement
Sandy Wong, MD, explains how clinicians and researchers can help educate others about myeloma.
Molly Stoddart, RN, BSN, is a clinical research nurse on the multiple myeloma team at the Winship Cancer Institute at Emory.
Sagar Lonial, MD, FACP, Editor-in-Chief of Blood Cancers Today, discusses Multiple Myeloma Awareness Month.
Dr. Raje reflects on the mentors who shaped her career, the evolution of myeloma treatment, and more.
Dr. Pickl discusses potential future uses and implications of a novel biomarker to predict responses to CAR-T in DLBCL.
Dr. Nabhan discusses his new book, "Toxic Exposure: The True Story behind the Monsanto Trials and the Search for Justice."
Advertisement
Winfried F. Pickl, MD, discusses a novel biomarker that can predict CAR-T responses in patients with DLBCL.
Mark Lawler, PhD, discusses insights from European Groundshot Report on survival trends and the future of cancer care.
Jennifer R. Brown, MD, PhD, and Anthony Mato, MD, MSCE, debate combinations versus sequencing approaches in CLL.
As 2023 begins, you'll want to listen to The HemOnc Pulse, a new podcast that brings you the latest in hematologic oncology.
Matthew Davids, MD, MMSc, of the Dana-Farber Cancer Institute, shares his hopes for CLL treatment and research in 2023.
As 2022 came to a close, the Blood Cancers Today Editorial Board shared their highlights from the year.
Sandy Wong, MD, of the University of California, San Francisco, shares what her hopes are in the New Year.
Amrita Krishnan, MD, FACP, and Saad Z. Usmani, MD, MBA, FACP, debate if CAR-T therapy will replace AHSCT in multiple myeloma.
The past few years have been more than a challenge for those of us in health care, but we have learned many lessons.
Jerald Radich, MD; and Christopher S. Hourigan, MD, DPhil, FACP, FRCP; discuss minimal residual disease.
Marina Konopleva, MD, PhD, discusses venetoclax resistance in AML during SOHO 2022
Marina Konopleva, MD, PhD, discusses her new role at the Albert Einstein College of Medicine and highlights from her career ...
We are entering the great era of immunotherapy in multiple myeloma, as we’ve had significant...
International Chronic Myeloid Leukemia (CML) Day takes place on September 22.
Advertisement
Advertisement
Editorial Board
Sagar Lonial, MD, FACPEditor-in-Chief | Chief Medical Officer of Winship Cancer Institute at Emory University School of Medicine
Elias Jabbour, MDAssociate Editor | Professor in the Department of Leukemia, Division of Cancer Medicine, MD Anderson Cancer Center
Thomas Martin, MDAssociate Editor | Clinical Research Director, UCSF Helen Diller Family Comprehensive Cancer Center
Jerald Radich, MDAssociate Editor | Professor in the Clinical Research Division and Kurt Enslein Endowed Chair at Fred Hutch
Laurie Sehn, MD, MPHAssociate Editor | Clinical Professor of Medical Oncology, British Columbia Cancer Centre for Lymphoid Cancer
Guillermo Garcia-Manero, MDAssociate Editor | Chief, Section of Myelodysplastic Syndromes, The University of Texas MD Anderson Cancer Center
Kami Maddocks, MDAssociate Editor | Professor of Clinical Internal Medicine in the Division of Hematology at The Ohio State University
670 Madison Ave.
Manalapan, NJ 07726